Shingles vaccine linked to 24% lower dementia risk
A study found that older adults who received the Shingrix shingles vaccine had a 24% lower risk of dementia over four years. The research analyzed data from over 500,000 people aged 66 and older in skilled nursing facilities. The findings suggest a possible link between the vaccine and reduced dementia risk.
A study of over 500,000 older adults found that those who got the Shingrix shingles vaccine were 24% less likely to develop dementia over four years. The research used Medicare data and health records from people in skilled nursing facilities.
The findings suggest that vaccines may have broader health benefits beyond their intended purpose, potentially helping to reduce the risk of dementia in older adults. This could influence public health strategies and encourage more people to get vaccinated.
The study highlights how medical advancements can have unexpected positive effects, offering hope and a sense of agency in preventing serious health issues like dementia. It shows how simple actions, like getting a vaccine, can contribute to better health outcomes.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.